首页 | 本学科首页   官方微博 | 高级检索  
检索        


Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT
Authors:Katrijn Michielsen  Ignace Vergote  Katya Op de beeck  Frederic Amant  Karin Leunen  Philippe Moerman  Christophe Deroose  Geert Souverijns  Steven Dymarkowski  Frederik De Keyzer  Vincent Vandecaveye
Institution:1. Department of Radiology, Medical Imaging Research Centre, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium
2. Department of Obstetrics and Gynaecology, Leuven Cancer Institute, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium
3. Department of Morphology and Molecular Pathology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium
4. Department of Nuclear Medicine, Medical Imaging Research Centre, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium
5. Department of Radiology, Jessa Ziekenhuis – Campus Virga Jessa, Stadsomvaart 11, 3500, Hasselt, Belgium
Abstract:

Objectives

To evaluate whole-body MRI with diffusion-weighted sequence (WB-DWI/MRI) for staging and assessing operability compared with CT and FDG-PET/CT in patients with suspected ovarian cancer.

Methods

Thirty-two patients underwent 3-T WB-DWI/MRI, 18?F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and CT before diagnostic open laparoscopy (DOL). Imaging findings for tumour characterisation, peritoneal and retroperitoneal staging were correlated with histopathology after DOL and/or open surgery. For distant metastases, FDG-PET/CT or image-guided biopsies were the reference standards. For tumour characterisation and peritoneal staging, WB-DWI/MRI was compared with CT and FDG-PET/CT. Interobserver agreement for WB-DWI/MRI was determined.

Results

WB-DWI/MRI showed 94 % accuracy for primary tumour characterisation compared with 88 % for CT and 94 % for FDG-PET/CT. WB-DWI/MRI showed higher accuracy of 91 % for peritoneal staging compared with CT (75 %) and FDG-PET/CT (71 %). WB-DWI/MRI and FDG-PET/CT showed higher accuracy of 87 % for detecting retroperitoneal lymphadenopathies compared with CT (71 %). WB-DWI/MRI showed excellent correlation with FDG-PET/CT (κ?=?1.00) for detecting distant metastases compared with CT (κ?=?0.34). Interobserver agreement was moderate to almost perfect (κ?=?0.58–0.91).

Conclusions

WB-DWI/MRI shows high accuracy for characterising primary tumours, peritoneal and distant staging compared with CT and FDG-PET/CT and may be valuable for assessing operability in ovarian cancer patients.

Key Points

? Whole-body MRI with diffusion weighting (WB-DWI/MRI) helps to assess the operability of suspected ovarian cancer. ? Interobserver agreement is good for primary tumour characterisation, peritoneal and distant staging. ? WB-DWI/MRI improves mesenteric/serosal metastatic spread assessment compared with CT and FDG-PET/CT. ? Retroperitoneal/cervical-thoracic nodal staging using qualitative DWI criteria was reasonably accurate. ? WB-DWI/MRI and FDG-PET/CT showed the highest diagnostic impact for detecting thoracic metastases.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号